SavedAdd your journal

Journals / Ege Tıp Dergisi / 2014 / Cilt: 53 - Sayı: 1

Sugammadex in a morbidly obese patient with prolonged residual neuromuscular blockade caused by vecuronium

Vekuronyum'a bağlı uzamış rezidüel nöromüsküler bloklu morbid obez hastada sugammadeks

Y. KARAMAN
Y. KARCIOĞLU
Y. GÜVENLİ
G. ŞAHİN
S. KARAARSLAN
M. GÖNÜLLÜ
Pages
43–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report we discuss a patient with morbid obesity who had prolonged residual neuromuscular

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Morbid obesity is an important risk factor in anesthesia practice in addition to its adverse effects on health.
📊
Key Findings & Data:Prolonged residual neuromuscular blockade which is unresponsive to cholinesterase inhibitors is frequent in morbidly obese patients.
💡
Conclusion & Impact:In this case report we discuss a patient with morbid obesity who had prolonged residual neuromuscular
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Morbid obesity is an important risk factor in anesthesia practice in addition to its adverse effects on health. Prolonged residual neuromuscular blockade which is unresponsive to cholinesterase inhibitors is frequent in morbidly obese patients. In this case report we discuss a patient with morbid obesity who had prolonged residual neuromuscular

Özet

Morbid obezite, kişi için günlük hayatta birçok sağlık sorunu oluşturmakla birlikte anestezi uygulamaları açısından da önemli bir risk faktörüdür. Morbid obez olgularda kolin esteraz enzim inhibitörlerine yanıt alınamayan rezüdüel nöromusküler blokajlara da sık rastlanmaktadır. Bu olgu sunumunda, sugammadeks ile uzamış nöromüsküler blokajın hızlı bir şekilde geriye döndürüldüğü morbid obez bir olgu tartışılmıştır.

🔖

Cite This Article

KARAMAN, Y., KARCIOĞLU, Y., GÜVENLİ, Y., ŞAHİN, G., KARAARSLAN, S., GÖNÜLLÜ, M. (2014). Sugammadex in a morbidly obese patient with prolonged residual neuromuscular blockade caused by vecuronium. Ege Tıp Dergisi, Cilt: 53 - Sayı: 1, 43–44. https://ajindex.com/articles/207566

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Shenkman Z, Shir Y, Brodsky JB. Peri operative management of the obese patient. British Journal of Anaesthesia 1993;70(3):349-59
  2. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the post anesthesia care unit. Anesth Analg 2008;107(1):130-7
  3. Gaszyński T, Szlachciński T, Jakubiak J, Gaszyński W. Reversal from non-depolarising neuromuscular blockade in the postoperative period. Anestezjol Intens Ter 2009;41(1):11-5
  4. Abrishami A, Ho J, Wong J, Yin L, Chung F. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database Syst Rev 2009; 7(4):CD007362
  5. Llauradó S, Sabaté A, Ferreres E, Camprubí I, Cabrera A. Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery. Anesthesiology 2012;117(1):93-8. 6.Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium- induced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth 2012;108(2):236 -9.